Stone Summit Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$250K Sell
2,936
-50
-2% -$4.46K 0.07% 135
2025
Q4
$236K Buy
2,986
+371
+14% +$29.1K 0.06% 136
2025
Q3
$209K Sell
2,615
-20
-0.8% -$1.71K 0.06% 143
2025
Q2
$240K Hold
2,635
0.07% 134
2025
Q1
$247K Sell
2,635
-105
-4% -$9.4K 0.08% 136
2024
Q4
$249K Hold
2,740
0.08% 132
2024
Q3
$284K Hold
2,740
0.09% 126
2024
Q2
$266K Hold
2,740
0.1% 126
2024
Q1
$247K Hold
2,740
0.09% 133
2023
Q4
$218K Buy
+2,740
New +$206K 0.08% 136
2023
Q3
Sell
-2,700
Closed -$208K 139
2023
Q2
$208K Hold
2,700
0.09% 135
2023
Q1
$203K Sell
2,700
-54
-2% -$4.01K 0.09% 131
2022
Q4
$217K Buy
+2,754
New +$206K 0.11% 124
2022
Q3
Sell
-2,754
Closed -$220K 125
2022
Q2
$220K Buy
+2,754
New +$215K 0.13% 124

Other funds holding CL

Stone Summit Wealth's CL Position: Q1 2026 in Review

Stone Summit Wealth reduced its Colgate-Palmolive (CL) stake by 1.7% in Q1 2026, selling an estimated $4.46K and leaving 2,936 shares worth $250K. The position accounts for 0.07% of the portfolio, ranked #135.

Stone Summit Wealth first reported a position in CL in Q2 2022 and has held it in 14 quarters since. The position peaked at $284K in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Stone Summit Wealth held 2,936 shares of Colgate-Palmolive worth $250K as of Q1 2026.
  • Stone Summit Wealth sold 50 Colgate-Palmolive shares in Q1 2026, an estimated $4.46K.
  • Colgate-Palmolive made up 0.07% of Stone Summit Wealth's portfolio in Q1 2026, its #135 holding.
  • Stone Summit Wealth first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 14 quarters since.
  • Stone Summit Wealth's Colgate-Palmolive position peaked at $284K in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Stone Summit Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.